keyword
https://read.qxmd.com/read/38552630/a-multifaceted-approach-to-global-health
#1
JOURNAL ARTICLE
Londa Schiebinger, Brandon E Turner, Ramanan Laxminarayan, Jessica Fanzo, Lucie Cluver, Mona Ibrahim
World Health Day underscores the scientific community's commitment to achieving health equity for all. It is paramount to eliminate bias in research that has traditionally focused on men, neglecting the specific needs of diverse populations. Innovative clinical trial designs are being developed with more inclusive enrollment. Ensuring equitable access to essential antibiotics, coupled with robust infection prevention and control measures, is vital to safeguarding public health. The pursuit of health equity extends beyond the realm of medicine...
March 21, 2024: Med
https://read.qxmd.com/read/38503661/vaccine-value-profile-for-klebsiella-pneumoniae
#2
JOURNAL ARTICLE
Ziyaad Dangor, Nicole Benson, James A Berkley, Julia Bielicki, Merijn W Bijsma, Jonathan Broad, Ed T Buurman, Alan Cross, Erin M Duffy, Kathryn E Holt, Pui-Ying Iroh Tam, Mark Jit, Konstantinos Karampatsas, Michael Katwere, Gaurav Kwatra, Ramanan Laxminarayan, Kirsty Le Doare, Robert Mboizi, Francesca Micoli, Catrin E Moore, Eve Nakabembe, Nichola R Naylor, Seamus O'Brien, Courtney Olwagen, Denasha Reddy, Charlene Rodrigues, David A Rosen, Manish Sadarangani, Padmini Srikantiah, Sharon M Tennant, Mateusz Hasso-Agopsowicz, Shabir A Madhi
Klebsiella pneumoniae causes community- and healthcare-associated infections in children and adults. Globally in 2019, an estimated 1.27 million (95% Uncertainty Interval [UI]: 0.91-1.71) and 4.95 million (95% UI: 3.62-6.57) deaths were attributed to and associated with bacterial antimicrobial resistance (AMR), respectively. K. pneumoniae was the second leading pathogen in deaths attributed to AMR resistant bacteria. Furthermore, the rise of antimicrobial resistance in both community- and hospital-acquired infections is a concern for neonates and infants who are at high risk for invasive bacterial disease...
March 18, 2024: Vaccine
https://read.qxmd.com/read/38484749/accelerating-antibiotic-access-and-stewardship-a-new-model-to-safeguard-public-health
#3
REVIEW
Jennifer Cohn, Marc Mendelson, Souha S Kanj, Nusrat Shafiq, Icaro Boszczowski, Ramanan Laxminarayan
This Personal View discusses the challenges faced, especially by low-income and middle-income countries (LMICs), in responding to the growing burden of bacterial antimicrobial resistance. Many patients in LMICs lack access to effective and affordable treatments needed to successfully treat patients. Meanwhile, traditional antimicrobial stewardship models face implementation challenges due to financial, health system, and human resource constraints. These constraints call for a paradigm shift from traditional high-income country-style antimicrobial stewardship, which is often resource intensive and aimed at cost containment, to a broader concept of sustainable access...
March 11, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38481788/estimates-of-hospitalisations-and-deaths-in-patients-with-covid-19-associated-with-undiagnosed-diabetes-during-the%C3%A2-first-phase-of-the-pandemic-in-eight-low-income-and-middle-income-countries-a-modelling-study
#4
JOURNAL ARTICLE
Amit Summan, Arindam Nandi, Brian Wahl, Sergio Carmona, Stefano Ongarello, Beatrice Vetter, Ramanan Laxminarayan
BACKGROUND: Patients with COVID-19 that had diagnosed chronic diseases - including diabetes - may experience higher rates of hospitalisation and mortality relative to the general population. However, the burden of undiagnosed co-morbidities during the pandemic has not been adequately studied. METHODS: We developed a model to estimate the hospitalisation and mortality burden of patients with COVID-19 that had undiagnosed type 1 and type 2 diabetes (UD). The retrospective analytical modelling framework was informed by country-level demographic, epidemiological and COVID-19 data and parameters...
April 2024: EClinicalMedicine
https://read.qxmd.com/read/38363081/brilaroxazine-lipogel-displays-antipsoriatic-activity-in-imiquimod-induced-mouse-model
#5
JOURNAL ARTICLE
Laxminarayan Bhat, Seema R Bhat, Arulprakash Ramakrishnan, Muthukumar Amirthalingam
BACKGROUND: Dopamine (D) and serotonin (5-HT) pathways contribute to psoriasis pathobiology. Disruptions incite increased inflammatory mediators, keratinocyte activation and deterioration, and worsening symptoms. Brilaroxazine (RP5063), which displays potent high binding affinity to D2/3/4 and 5-HT1A/2A/2B/7 receptors and a moderate affinity to serotonin transporter (SERT), may affect the underlying psoriasis pathology. METHODS: An imiquimod-induced psoriatic mouse model (BALB/c) evaluated brilaroxazine's activity in a topical liposomal-aqueous gel (Lipogel) formulation...
February 2024: Skin Research and Technology
https://read.qxmd.com/read/38343010/assessment-of-x-ray-efficacy-for-intraoperative-microneedle-retrieval-using-a-cadaveric-model
#6
JOURNAL ARTICLE
Sara C Chaker, Ya-Ching Hung, Ariel A Vinson, Mariam Saad, Galen Perdikis, Panambur Laxminarayan Bhandari
INTRODUCTION: Institutional protocols often mandate the use of x-rays when a microneedle is lost intraoperatively. Although x-rays can reliably show a macroneedle, the benefit of x-rays in detecting microneedles in human tissues has not been established as available data on this topic are investigated in anthropometric models. The current study aims to evaluate whether x-rays can reliably detect retained microneedles in a human cadaveric model. We hypothesize that microneedles would be detected at a significantly lower rate than macroneedles by x-ray in human tissues...
February 2024: Microsurgery
https://read.qxmd.com/read/38278160/antimicrobial-resistance-and-the-great-divide-inequity-in-priorities-and-agendas-between-the-global-north-and-the-global-south-threatens-global-mitigation-of-antimicrobial-resistance
#7
REVIEW
Marc Mendelson, Ramanan Laxminarayan, Direk Limmathurotsakul, Samuel Kariuki, Martha Gyansa-Lutterodt, Esmita Charani, Sanjeev Singh, Kamini Walia, Ana C Gales, Mirfin Mpundu
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions required to mitigate the antimicrobial resistance pandemic are a direct threat to success. We argue that evidence suggests a need to prioritise and support infection prevention interventions (ie, clean water and safe sanitation, increased vaccine coverage, and enhanced infection prevention measures for food production in the Global South contrary to the focus on research and development of new antibiotics in the Global North) and to recalibrate global funding resources to address this need...
January 23, 2024: Lancet Global Health
https://read.qxmd.com/read/38244561/the-tokyo-2020-and-beijing-2022-olympic-games-held-during-the-covid-19-pandemic-planning-outcomes-and-lessons-learnt
#8
REVIEW
Brian McCloskey, Tomoya Saito, Satoshi Shimada, Chiaki Ikenoue, Tina Endericks, Lucia Mullen, Pau Mota, Chirag K Kumar, Ramanan Laxminarayan, Richard Budgett, David Heymann, Alimuddin Zumla
The COVID-19 pandemic profoundly affected all mass gatherings for sporting and religious events, causing cancellation, postponement, or downsizing. On March 24, 2020, the Japanese Government, the Tokyo Organising Committee of the Olympic and Paralympic Games, and the International Olympic Committee decided to postpone the Tokyo 2020 Olympic and Paralympic Games until the summer of 2021. With the emergence of SARS-CoV-2, the potential creation of a superspreading event that would overwhelm the Tokyo health system was perceived as a risk...
January 17, 2024: Lancet
https://read.qxmd.com/read/38156209/dr-ramanan-laxminarayan-antimicrobial-resistance-we-may-be-in-the-darkest-hour-before-the-dawn
#9
EDITORIAL
Ramanan Laxminarayan
No abstract text is available yet for this article.
2023: Antimicrob Steward Healthc Epidemiol
https://read.qxmd.com/read/38123601/understanding-the-value-of-biobank-attributes-to-researchers-using-a-conjoint-experiment
#10
JOURNAL ARTICLE
Deepshikha Batheja, Srishti Goel, Warren Fransman, Anna Mantsoki, Stefano Ongarello, Ramanan Laxminarayan
Biobanks are important in biomedical and public health research, and future healthcare research relies on their strength and capacity. However, there are financial challenges related to the operation of commercial biobanks and concerns around the commercialization of biobanks. Non-commercial biobanks depend on grant funding to operate and could be valuable to researchers if they can enable access to quality specimens at lower costs. The objective of this study is to estimate the value of specific biobank attributes...
December 20, 2023: Scientific Reports
https://read.qxmd.com/read/38028162/response-to-antimicrobial-resistance-in-south-east-asia-region
#11
REVIEW
Benyamin Sihombing, Rajesh Bhatia, Rahul Srivastava, Tjandra Yoga Aditama, Ramanan Laxminarayan, Suman Rijal
Antimicrobial resistance (AMR) inflicts significant mortality, morbidity and economic loss in the 11 countries in the WHO South-East Asia Region (SEAR). With technical assistance and advocacy from WHO, all countries have developed their respective National Action Plans on AMR that are aligned with the Global Action Plan. Historically, the WHO Regional Office has been proactive in advocacy at the highest political level. The past decade has seen an enhancement of the country's capacity to combat AMR through national efforts catalyzed and supported through several WHO initiatives at all levels-global, regional and country levels...
November 2023: Lancet Reg Health Southeast Asia
https://read.qxmd.com/read/37983514/coupled-models-of-genomic-surveillance-and-evolving-pandemics-with-applications-for-timely-public-health-interventions
#12
JOURNAL ARTICLE
Baltazar Espinoza, Aniruddha Adiga, Srinivasan Venkatramanan, Andrew Scott Warren, Jiangzhuo Chen, Bryan Leroy Lewis, Anil Vullikanti, Samarth Swarup, Sifat Moon, Christopher Louis Barrett, Siva Athreya, Rajesh Sundaresan, Vijay Chandru, Ramanan Laxminarayan, Benjamin Schaffer, H Vincent Poor, Simon A Levin, Madhav V Marathe
Disease surveillance systems provide early warnings of disease outbreaks before they become public health emergencies. However, pandemics containment would be challenging due to the complex immunity landscape created by multiple variants. Genomic surveillance is critical for detecting novel variants with diverse characteristics and importation/emergence times. Yet, a systematic study incorporating genomic monitoring, situation assessment, and intervention strategies is lacking in the literature. We formulate an integrated computational modeling framework to study a realistic course of action based on sequencing, analysis, and response...
November 28, 2023: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/37898101/a-novel-combination-therapy-with-cabozantinib-and-honokiol-effectively-inhibits-c-met-nrf2-induced-renal-tumor-growth-through-increased-oxidative-stress
#13
JOURNAL ARTICLE
Laxminarayan Rawat, Murugabaskar Balan, Yuzuru Sasamoto, Akash Sabarwal, Soumitro Pal
Receptor tyrosine kinase (RTK), c-Met, is overexpressed and hyper active in renal cell carcinoma (RCC). Most of the therapeutic agents mediate cancer cell death through increased oxidative stress. Induction of c-Met in renal cancer cells promotes the activation of redox-sensitive transcription factor Nrf2 and cytoprotective heme oxygenase-1 (HO-1), which can mediate therapeutic resistance against oxidative stress. c-Met/RTK inhibitor, Cabozantinib, has been approved for the treatment of advanced RCC. However, acquired drug resistance is a major hurdle in the clinical use of cabozantinib...
December 2023: Redox Biology
https://read.qxmd.com/read/37861679/discovery-of-mk-1468-a-potent-kinome-selective-brain-penetrant-amidoisoquinoline-lrrk2-inhibitor-for-the-potential-treatment-of-parkinson-s-disease
#14
JOURNAL ARTICLE
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, Mitchell H Keylor, Michael Ardolino, Xin Yan, Rebecca Johnson, Rachel L Palte, Spencer E McMinn, Lisa Nogle, Jing Su, Dong Xiao, Jennifer Piesvaux, Susi Lee, Laxminarayan G Hegde, Janice D Woodhouse, Robert Faltus, Lily Y Moy, Tina Xiong, Paul J Ciaccio, Kara Pearson, Mayankbhai Patel, Karin M Otte, Cheryl E G Leyns, Matthew E Kennedy, David Jonathan Bennett, Erin F DiMauro, Matthew J Fell, Peter H Fuller
Genetic mutation of the leucine-rich repeat kinase 2 (LRRK2) protein has been associated with Parkinson's disease (PD), a disabling and progressive neurodegenerative disorder that is devoid of efficacious disease-modifying therapies. Herein, we describe the invention of an amidoisoquinoline (IQ)-derived LRRK2 inhibitor lead chemical series. Knowledge-, structure-, and property-based drug design in concert with rigorous application of in silico calculations and presynthesis predictions enabled the prioritization of molecules with favorable CNS "drug-like" physicochemical properties...
October 20, 2023: Journal of Medicinal Chemistry
https://read.qxmd.com/read/37833540/modeling-of-malaria-vaccine-effectiveness-on-disease-burden-and-drug-resistance-in-42-african-countries
#15
JOURNAL ARTICLE
Alisa Hamilton, Fardad Haghpanah, Mateusz Hasso-Agopsowicz, Isabel Frost, Gary Lin, Emily Schueller, Eili Klein, Ramanan Laxminarayan
BACKGROUND: The emergence of antimalarial drug resistance poses a major threat to effective malaria treatment and control. This study aims to inform policymakers and vaccine developers on the potential of an effective malaria vaccine in reducing drug-resistant infections. METHODS: A compartmental model estimating cases, drug-resistant cases, and deaths averted from 2021 to 2030 with a vaccine against Plasmodium falciparum infection administered yearly to 1-year-olds in 42 African countries...
October 13, 2023: Commun Med (Lond)
https://read.qxmd.com/read/37800178/electroencephalographic-markers-from-routine-sleep-discriminate-individuals-who-are-vulnerable-or-resilient-to-sleep-loss
#16
JOURNAL ARTICLE
Manivannan Subramaniyan, Chao Wang, Srinivas Laxminarayan, Francisco G Vital-Lopez, John D Hughes, Tracy J Doty, Jaques Reifman
Sleep loss impairs cognition; however, individuals differ in their response to sleep loss. Current methods to identify an individual's vulnerability to sleep loss involve time-consuming sleep-loss challenges and neurobehavioural tests. Here, we sought to identify electroencephalographic markers of sleep-loss vulnerability obtained from routine night sleep. We retrospectively analysed four studies in which 50 healthy young adults (21 women) completed a laboratory baseline-sleep phase followed by a sleep-loss challenge...
October 6, 2023: Journal of Sleep Research
https://read.qxmd.com/read/37727084/global-patterns-and-correlates-in-the-emergence-of-antimicrobial-resistance-in-humans
#17
JOURNAL ARTICLE
Emma Mendelsohn, Noam Ross, Carlos Zambrana-Torrelio, T P Van Boeckel, Ramanan Laxminarayan, Peter Daszak
Antimicrobial resistance (AMR) is a critical global health threat, and drivers of the emergence of novel strains of antibiotic-resistant bacteria in humans are poorly understood at the global scale. We examined correlates of AMR emergence in humans using global data on the origins of novel strains of AMR bacteria from 2006 to 2017, human and livestock antibiotic use, country economic activity and reporting bias indicators. We found that AMR emergence is positively correlated with antibiotic consumption in humans...
September 27, 2023: Proceedings. Biological Sciences
https://read.qxmd.com/read/37572686/covid-19-pandemic-a-catalyst-for-accelerating-global-action-on-patient-safety
#18
JOURNAL ARTICLE
Rebecca Grant, Daniel Benamouzig, Howard Catton, Vincent Chi-Chung Cheng, Neelam Dhingra, Ramanan Laxminarayan, Helena Legido-Quigley, Susanna Lorenzo Martinez, Kadar Marikar, Marc Mendelson, Pierre Parneix, Eli Perencevich, Hardeep Singh, Sarah Tschudin-Sutter, Shin Ushiro, Evelyn Wesangula, Céline Gardiol, Gerald Dziekan, Stephan Harbarth, Didier Pittet
No abstract text is available yet for this article.
August 9, 2023: Lancet Infectious Diseases
https://read.qxmd.com/read/37449298/early-discontinuation-of-antibiotics-in-patients-admitted-with-clinically-suspected-serious-infection-but-negative-cultures-retrospective-cohort-study-of-practice-patterns-and-outcomes-at-111%C3%A2-us-hospitals
#19
JOURNAL ARTICLE
Sameer S Kadri, Sarah Warner, Chanu Rhee, Michael Klompas, Dean Follmann, Bruce J Swihart, Ramanan Laxminarayan, Eili Klein
BACKGROUND: The optimal duration for antibiotics in patients hospitalized with culture-negative serious infection (CNSI) is unknown. We compared outcomes in patients with CNSI treated with 3 or 4 vs ≥5 days of antibiotics. METHODS: CNSI was identified among adults admitted to 111 US hospitals between 2009 and 2014 via electronic health record data, defined as suspected serious infection (blood cultures drawn and ≥3 days of antibiotics) and negative culture- and nonculture-based tests for infection...
July 2023: Open Forum Infectious Diseases
https://read.qxmd.com/read/37435340/a-rare-case-of-extensor-digitorum-communis-rupture-due-to-pancarpal-arthritis
#20
Salman Shiraz, Laxminarayan Bhandari
We report the case of a 71-year-old man who presented to our clinic with extensor digitorum communis (EDC) tendon rupture associated with pancarpal arthritis. He presented with a history of prolonged chainsaw usage. Later that day upon waking up, he noticed an inability to extend his small and ring fingers. On examination, the EDC of the ring and small fingers showed zero power. Radiographs of the wrist joint showed pancarpal arthritis with a dorsally displaced lunate along with distal radio-ulnar joint (DRUJ) osteoarthritis (OA)...
June 2023: Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India
keyword
keyword
22373
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.